Seladelpar (MBX-8025), a Selective PPAR-δ Agonist, in Patients with Primary Biliary Cholangitis with an Inadequate Response to Ursodeoxycholic Acid: a Double-Blind, Randomised, Placebo-Controlled, Phase 2, Proof-of-concept Study David Jones , Pol F. Boudes , Mark G. Swain , Christopher L. Bowlus , Michael R. Galambos , Bruce R. Bacon , Yvonne Doerffel , Norman Gitlin , Stuart C. Gordon , Joseph A. Odin , David Sheridan , Markus-Alexander Woerns , Virginia Clark , Linsey Corless , Heinz Hartmann , Mark E. Jonas , Andreas E. Kremer , George F. Mells , Peter Buggisch , Bradley L. Freilich , Cynthia Levy , John M. Vierling , David E. Bernstein , Marek Hartleb , Ewa Janczewska , Fedja Rochling , Hemant Shah , Mitchell L. Shiffman , John H. Smith , Yun-Jung Choi , Alexandra Steinberg , Monika Varga , Harinder Chera , Robert Martin , Charles A. McWherter , Gideon M. Hirschfield LANCET GASTROENTEROLOGY & HEPATOLOGY（2017）
Key words
Primary Sclerosing Cholangitis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
